Analeah Heidt
Health Technology
Profile
Analeah Heidt worked as an Executive Vice President-Translational Research at Inhibrx, Inc.
Former positions of Analeah Heidt
| Companies | Position | End |
|---|---|---|
| INHIBRX, INC. | Corporate Officer/Principal | 31/07/2021 |
Experiences
Positions held
Linked companies
| Private companies | 1 |
|---|---|
Inhibrx, Inc.
 Inhibrx, Inc. BiotechnologyHealth Technology Inhibrx, Inc., is a clinical stage biotechnology company, focuses on developing pipeline of novel biologic therapeutic candidates. The firm’s pipeline is focused on oncology, orphan diseases and infectious diseases. It utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary sdAb platform. The company was founded by Mark Paul Lappe, Quinn Deveraux and Brendan P. Eckelman in April 2010 and is headquartered La Jolla, CA. | Health Technology |
- Stock Market
- Insiders
- Analeah Heidt
